{Reference Type}: Interview
{Title}: First person profile: Dr Carl June: Dr June recently participated on a panel with the FDA to discuss the next steps needed to expand CAR T-cell therapy into areas other than blood cancers.
{Author}: Nierengarten MB;
{Journal}: Cancer
{Volume}: 130
{Issue}: 14
{Year}: 2024 Jul 15
{Factor}: 6.921
{DOI}: 10.1002/cncr.35420